サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1643991

インフルエンザワクチンの世界市場：2033年までの機会と戦略

Influenza Vaccines Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 291 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
インフルエンザワクチンの世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 291 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のインフルエンザワクチン市場は2018年に58億4,770万米ドルと評価され、CAGR6.00%以上で2023年まで成長しました。

ワクチン接種プログラムの拡大

ワクチン接種プログラムの拡大は、これまでのインフルエンザワクチン市場の成長を牽引しました。ワクチン接種とは、特定の感染症に対する免疫を体につけるためにワクチンを投与するプロセスを指します。ワクチン接種プログラムの拡大は、感染症の蔓延を防ぎ、ヘルスケアコストを削減し、弱い立場にある人々を深刻な病気や合併症から守る効果があることが原動力となっています。インフルエンザワクチンは、季節性インフルエンザの流行を予防するための広くアクセス可能で効果的な手段を提供することで、ワクチン接種の拡大において重要な役割を果たしており、病気や入院の減少、ヘルスケアシステムの負担軽減に役立っています。例えば、2024年10月、欧州を拠点とする統治機関である欧州委員会が発表した報告書によると、欧州委員会は最大42億回分のCOVID-19ワクチンを確保しており、2023年8月現在、EUの成人人口の84.8%が少なくとも1回はワクチン接種を受けています。そのため、ワクチン接種プログラムの拡大がインフルエンザワクチン市場の成長に寄与しました。

目次

第1章 エグゼクティブサマリー

  • インフルエンザワクチン-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • インフルエンザワクチン市場定義とセグメンテーション
  • ワクチンタイプ別の市場セグメンテーション
    • 不活性化
    • 生弱毒化
    • 組み換え
  • 価数別の市場セグメンテーション
    • 四価
    • 三価
  • 投与経路別の市場セグメンテーション
    • 注射
    • 鼻スプレー
  • 年齢層別の市場セグメンテーション
    • 小児
    • 成人
  • 流通チャネル別の市場セグメンテーション
    • 病院と薬局
    • 政府と機関の供給
    • その他の流通チャネル

第7章 主要な市場動向

  • インフルエンザワクチンの革新を推進する技術の進歩
  • インフルエンザワクチン生産能力の拡大
  • インフルエンザワクチン開発の進歩
  • 市場プレーヤー間の戦略的パートナーシップとコラボレーション

第8章 インフルエンザワクチン市場：マクロ経済シナリオ

  • COVID-19の影響：インフルエンザワクチン市場
  • ウクライナ戦争の影響：インフルエンザワクチン市場
  • 高インフレの影響：インフルエンザワクチン市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018-2023
    • 市場促進要因、2018-2023
    • 市場抑制要因、2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因、2023-2028
    • 市場抑制要因、2023-2028

第10章 世界のインフルエンザワクチン市場：セグメンテーション

  • 世界のインフルエンザワクチン市場：ワクチンタイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のインフルエンザワクチン市場：価数別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のインフルエンザワクチン市場：投与経路別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のインフルエンザワクチン市場：年齢層別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のインフルエンザワクチン市場：流通チャネル別、実績と予測, 2018-2023, 2028F, 2033F

第11章 インフルエンザワクチン市場：地域・国別分析

  • 世界のインフルエンザワクチン市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のインフルエンザワクチン市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Sanofi S.A.
  • Seqirus（CSL Limited）
  • GlaxoSmithKline plc
  • Daiichi Sankyo Co. Ltd
  • Pfizer Inc

第20章 その他の大手企業と革新的企業

  • Abbott Laboratories
  • AstraZeneca Plc
  • Sinovac Biotech Ltd
  • Serum Institute of India
  • BioDiem Ltd
  • Takeda Pharmaceutical Company Limited
  • EMERGENT BIOSOLUTIONS INC
  • BiondVax Pharmaceuticals Ltd
  • Gamma Vaccines Pty Ltd
  • Osivax
  • Vaxart Inc
  • Vaxess Technologies Inc
  • Biken Techno Corp
  • Johnson & Johnson
  • Flugen Inc

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • GSK Acquired CureVac
  • AstraZeneca Acquired Icosavax
  • GSK Acquired Affinivax

第24章 機会と戦略

  • 世界のインフルエンザワクチン市場2028：新たな機会を提供する国
  • 世界のインフルエンザワクチン市場2028：新たな機会を提供するセグメント
  • 世界のインフルエンザワクチン市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 インフルエンザワクチン市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1454

Influenza vaccines are biological preparations designed to provide immunity against the influenza virus, commonly known as the flu. These vaccines are primarily utilized by individuals across various age groups, including children, adults and the elderly, to prevent seasonal influenza infections.

The influenza vaccines market consists of sales, by entities (organizations, sole traders or partnerships), of vaccines designed to protect against the seasonal influenza virus. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight off the virus. They are designed to protect against the most prevalent strains of the virus, which are updated annually based on predictions of circulating flu strains, making them a critical tool in preventing seasonal outbreaks and reducing the severity of symptoms in those who contract the virus.

The global influenza vaccines market was valued at $5,847.70 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Expansion Of Vaccination Programs

Expansion of vaccination programs drove the growth of the influenza vaccine market during this historic period. Vaccination refers to the process of administering a vaccine to help the body develop immunity against a specific infectious disease. The expansion of vaccination programs are driven by their effectiveness in preventing the spread of infectious diseases, reducing healthcare costs and protecting vulnerable populations from serious illness and complications. The influenza vaccine plays a key role in the expansion of vaccination by providing a widely accessible and effective means of preventing seasonal flu outbreaks, helping to reduce illness, hospitalizations and the burden on healthcare systems. For instance, in October 2024, according to a report published by the European Commission, a European-based governing body, the European Commission has secured up to 4.2 billion doses of COVID-19 vaccines and as of August 2023, 84.8% of the EU adult population has been vaccinated at least once. Therefore, expansion of vaccination programs contributed to the growth of the influenza vaccine market.

Technological Advancement To Drive Innovation In The Influenza Vaccine

Major companies in the influenza vaccine market are leveraging technological advancements, such as the development of advanced Quadrivalent Influenza vaccines, to gain a competitive edge. These vaccines are designed to protect against four different influenza virus strains. For example, in March 2024, Cadila Pharmaceuticals Limited, an Indian pharmaceutical company, launched the Cadiflu Tetra Vaccine. This innovative product aims to significantly reduce the incidence of influenza, lessen the severity of the illness and curb the transmission of the virus. The Cadiflu Tetra Vaccine offers unique features, including quadrivalent protection, an enhanced immune response through its advanced formulation and a focus on improving community health by reducing virus transmission.

Sanofi SA was the largest competitor with a 36.60% share of the market, followed by Seqirus (CSL Limited) and GlaxoSmithKline Plc

Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza vaccines market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for influenza vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider influenza vaccines market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type, by valency, by route of administration, by age group and by distribution channel.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the influenza vaccines market.

Global Market Size And Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by valency, by route of administration, by age group and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for influenza vaccines providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Vaccine: Inactivated; Live Attenuated; Recombinant
  • 2) By Valency: Quadrivalent; Trivalent
  • 3) By Route Of Administration: Injection; Nasal Spray
  • 4) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels
  • 5) By Age Group: Pediatric; Adult
  • Companies Mentioned: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza vaccines indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Influenza Vaccines - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Influenza Vaccines Market Definition And Segmentations
  • 6.4 Market Segmentation By Vaccine Type
    • 6.4.1 Inactivated
    • 6.4.2 Live Attenuated
    • 6.4.3 Recombinant
  • 6.5 Market Segmentation By Valency
    • 6.5.1 Quadrivalent
    • 6.5.2 Trivalent
  • 6.6 Market Segmentation By Route Of Administration
    • 6.6.1 Injection
    • 6.6.2 Nasal Spray
  • 6.7 Market Segmentation By Age Group
    • 6.7.1 Pediatric
    • 6.7.2 Adult
  • 6.8 Market Segmentation By Distribution Channel
    • 6.8.1 Hospitals And Pharmacies
    • 6.8.2 Government And Institutional Supply
    • 6.8.3 Other Distribution Channels

7 Major Market Trends

  • 7.1 Technological Advancement To Drive Innovation In The Influenza Vaccine
  • 7.2 Expansion Of Influenza Vaccine Production Capacity
  • 7.3 Advancements In Influenza Vaccine Development
  • 7.4 Strategic Partnerships And Collaborations Among Market Players

8 Influenza Vaccines Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Influenza Vaccines Market
  • 8.2 Impact Of The War In Ukraine On The Influenza Vaccines Market
  • 8.3 Impact Of High Inflation On The Influenza Vaccines Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Influenza Vaccines Market Segmentation

  • 10.1 Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Influenza Vaccines Market, Regional and Country Analysis

  • 11.1 Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Influenza Vaccines Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Influenza Vaccines Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major companies
  • 14.2 Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Influenza Vaccines Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Influenza Vaccines Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Influenza Vaccines Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Major Companies
  • 17.2 Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.2.1 Market Overview
    • 18.2.2 Region Information
    • 18.2.3 Market Information
    • 18.2.4 Background Information
    • 18.2.5 Government Initiatives
    • 18.2.6 Regulations
    • 18.2.7 Regulatory Bodies
    • 18.2.8 Major Associations
    • 18.2.9 Taxes Levied
    • 18.2.10 Corporate Tax Structure
    • 18.2.11 Investments
    • 18.2.12 Major Companies
  • 18.3 Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Sanofi S.A.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Seqirus (CSL Limited)
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 GlaxoSmithKline plc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Daiichi Sankyo Co. Ltd
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Pfizer Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Abbott Laboratories
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 AstraZeneca Plc
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Sinovac Biotech Ltd
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Serum Institute of India
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 BioDiem Ltd
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 Takeda Pharmaceutical Company Limited
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 EMERGENT BIOSOLUTIONS INC
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 BiondVax Pharmaceuticals Ltd
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Gamma Vaccines Pty Ltd
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.10 Osivax
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 Vaxart Inc
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 Vaxess Technologies Inc
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 Biken Techno Corp
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services
  • 20.14 Johnson & Johnson
    • 20.14.1 Company Overview
    • 20.14.2 Products and Services
  • 20.15 Flugen Inc
    • 20.15.1 Company Overview
    • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 GSK Acquired CureVac
  • 23.2 AstraZeneca Acquired Icosavax
  • 23.3 GSK Acquired Affinivax

24 Opportunities And Strategies

  • 24.1 Global Influenza Vaccines Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Influenza Vaccines Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Influenza Vaccines Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Influenza Vaccines Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer